TY  - JOUR 
AU  - Myers, John Peterson
AU  - Saal, Frederick S. vom
AU  - Akingbemi, Benson T.
AU  - Arizono, Koji
AU  - Belcher, Scott
AU  - Colborn, Theo
AU  - Chahoud, Ibrahim
AU  - Crain, D. Andrew
AU  - Farabollini, Francesca
AU  - Guillette, Louis J.
AU  - Hassold, Terry
AU  - Ho, Shuk-Mei
AU  - Hunt, Patricia A.
AU  - Iguchi, Taisen
AU  - Jobling, Susan
AU  - Kanno, Jun
AU  - Laufer, Hans
AU  - Marcus, Michele
AU  - McLachlan, John A.
AU  - Nadal, Ángel
AU  - Oehlmann, Jörg
AU  - Olea Serrano, Nicolás
AU  - Palanza, Paola
AU  - Parmigiani, Stefano
AU  - Rubin, Beverly S.
AU  - Schoenfelder, Gilbert
AU  - Sonnenschein, Carlos
AU  - Soto, Ana M.
AU  - Talsness, Chris E.
AU  - Taylor, Julia A.
AU  - Vandenberg, Laura N.
AU  - Vandenbergh, John G.
AU  - Vogel, Sarah
AU  - Watson, Cheryl S.
AU  - Welshons, Wade V.
AU  - Zoeller, Thomas R.
PY  - 2009
SN  - 0091-6765
UR  - http://hdl.handle.net/10481/24821
AB  - BACKGROUND In their safety evaluations of bisphenol A (BPA), the U.S. Food and Drug Administration (FDA) and a counterpart in Europe, the European Food Safety Authority (EFSA), have given special prominence to two industry-funded studies that adhered...
LA  - eng
PB  - National Institute of Environmental Health Sciences
KW  - Bisphenol A
KW  - Endocrine disruptors
KW  - Food and Drug Administration (FDA)
KW  - Good laboratory practices (GLP)
KW  - Low-dose
KW  - Nonmonotonic
KW  - Positive control
TI  - Why Public Health Agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A
ER  -